Current management of onychomycosis: An overview

Dermatologic Clinics

Volumn 15, Issue 1, 1997, Pages 121-135

  Gupta, A K ^a   Scher, R K ^a   De Doncker, P ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; BIFONAZOLE; CHLOROXYLENOL; CICLOPIROXOLAMINE; CLOTRIMAZOLE; FLUCONAZOLE; FLUOROURACIL; GLUTARALDEHYDE; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE; TIOCONAZOLE;

ANTIFUNGAL ACTIVITY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; FOOT DISEASE; HUMAN; ONYCHOMYCOSIS; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; RELAPSE; REVIEW; TREATMENT PLANNING;

EID: 0031012548     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70420-4     Document Type: Article

References (156)

1. B.B. Abrams H. Hanel T. Hoehler Ciclopirox olamine: A hydroxypyridone antifungal agent Clin Dermatol 9 1991 471 477
2. D.B. Apfelberg E. Rothermel A. Widtfeldt Preliminary report on use of carbon dioxide laser in podiatry J Am Podiatr Med Assoc 74 1984 509 513
3. R. Arenas J. Dominguez-Cherit L.M. Fernández Open randomized comparison of itraconazole versus terbinafine in onychomycosis Int J Dermatol 34 1993 138 143
4. R. Arenas G. Fernandez L. Dominguez Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent Int J Dermatol 30 1991 586 589
5. R.R. Assaf B.E. Elewski Intermittent fluconazole dosing in patients with onychomycosis: Results of a pilot study J Am Acad Dermatol 35 1996 216 219
6. H.P. Baden Treatment of distal onychomycosis with avulsion and topical antifungal agents under occlusion Arch Dermatol 130 1994 558 559
7. H.P. Baden J. Kubilus A comparative study of the immunologic properties of hoof and nail fibrous proteins J Invest Dermatol 83 1984 327
8. F.K. Bagatell Topical therapy for onychomycosis Arch Dermatol 113 1977 378
9. E.M. Bailey D.J. Krakovsky M.J. Rybak The triazole antifungal agents: A review of itraconazole and fluconazole Pharmacotherapy 10 1990 146 153
10. J.A. Balfour D. Faulds Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses Drugs 43 1992 259 284
11. R. Baran Amorolfine nail lacquer: A new transungual delivery system for nail mycoses JAMA South-east Asia Supplement 9 1993 5 6
12. R. Baran P. DeDoncker Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals Acta Derm Venereol, 76 1996 82 93
13. R. Baran R.P.R. Dawber Investigations and some physiochemical properties of nails R. Baran R.P.R. Dawber Diseases of the Nails and Their Management 1984 Blackwell Oxford 81 104
14. R. Baran R.J. Hay Partial surgical avulsion of the nail in onychomycosis Clin Exp Dermatol 10 1985 413 418
15. F. Baudraz-Rosselet T. Rakosi P.B. Wili Treatment of onychomycosis with terbinafine Br J Dermatol 126 1992 40 46
16. B. Bentley-Phillips The treatment of onychomycosis with miconazole tincture South Afr Med J 62 1981 57 58
17. D. Berney K. Schuh 125. Heterocyclic spiro-naphthalenones Part 1: Synthesis and reactions of some spiro [(1 H-naphthalenome)]-1, 3,-piperidines Helv Chir Acta 61 1978 1262 1273
18. J.E. Birnbaum Pharmacology of the allylamines J Am Acad Dermatol 23 1990 782 785
19. M. Borgers H. Van den Bossche The mode of action of antifungal drugs H.B. Levine Ketoconazole in the management of fungal disease 1982 Adis Press New York 25 47
20. M. Bräutigam S. Nolting R.E. Schopf Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection BMJ 311 1995 919 922
21. D. Buck D. Nidorf J. Addino Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole J Fam Pract 38 1994 601 605
22. T.J. Buselmeier Combination urea and salicylic acid ointment nail avulsion in nondystrophic nails: A follow-up observation Cutis 25 1980 397 405
23. G. Cauwenbergh H. Degreef J. Heykants Pharmacokinetic profile of orally administered itraconazole in human skin J Am Acad Dermatol 18 1988 263 268
24. C.G. Ceschin-Roques H. Hänel S.M. Pruja-Bougaret Ciclopiroxolamine cream 1%: In vitro and in vivo penetration into the stratum corneum Skin Pharmacol 4 1991 95 99
25. Y.M. Clayton In vitro activity of terbinafine Clin Exp Dermatol 14 1989 101 103
26. B. Coldiron Recalcitrant onychomycosis of the toenails successfully treated with fluconazole Arch Dermatol 128 1992 909 910
27. B. Cribier E. Grosshans Efficacité et tolérance de la terbinafine (Lamisil) dans une série de 50 onychomycoses ä dermatophytes Ann Dermatol Venereol 121 1994 15 20
28. N. Dabrowa J.W. Landau V.D. Newcomer Antifungal activity of glutaraldehyde in vitro Arch Dermatol 105 1972 555 557
29. R.P.R. Dawber The ultrastructure and growth of human nails Arch Dermatol Res 269 1980 197 204
30. R.P.R. Dawber D.A.R. DeBerker R. Baran Science of the nail apparatus R. Baran Diseases of the nails and their management 1994 Oxford, Blackwell Osney Mead 1 34
31. P. Doncker De Pharmacokinetics of onychomycosis P.H. Jacobs L. Nall Fungal Disease: Biology. Immunology & Diagnosis 1996 Marcel Dekker New York
32. P. Doncker De J. Decroix G.E. Pierard Antifungal pulse therapy for onychomycosis Arch Dermatol 132 1996 34 41
33. P. Doncker De G.E. Pierard Acquired nail beading in patients receiving itraconazole—An indicator of faster nail growth? A study using optical profilometry Clin Exp Dermatol 19 1994 404 406
34. De Doncker P, Scher R, Baran R, et al: De Doncker P, Scher R, Baran R, et al: Efficacy of itraconazole in the treatment of nondermatophyte onychomycosis of the toenail. J Am Acad Dermatol, in press
35. P. De Doncker J. Lint Van P. Dockx Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis Cutis 56 1995 180 183
36. S.M. De Padova-Elder C.M. Ditre G.R. Kantor Candidiasis endocrinopathy syndrome Arch Dermatol 130 1994 19 22
37. H. Dermoumi In vitro susceptibility of fungal isolates of clinically important specimens to itraconazole, fluconazole, and amphotericin B Chemotherapy (Basel) 40 1994 92 98
38. D. Dompmartin A. Dompmartin A.M. Deluol Onychomycosis and AIDS: Treatment with topical ciclopirox olamine Int J Dermatol 29 1990 233
39. B.E. Elewski Onychomycosis Fitzpatrick's Journal of Clinical Dermatology 1 1994 48 54
40. M.D. English Trichophyton rubrum infection in families BMJ 1 1957 744 746
41. A. Espinel-Ingroff S. Shadomy R.J. Gebhart In vitro studies with R 51,211 (Itraconazole) Antimicrob Agents Chemother 26 1984 5 9
42. J. Faergemann C. Anderson K. Hersle Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis J Am Acad Dermatol 32 1995 750 753
43. Faergemann J, Laufen H: Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toenails with fluconazole 150 mg once weekly. In press, 1996.
44. J. Faergemann G. Swanbeck Treatment of onychomycosis with a propylene glycol-urea-lactic acid solution Mycoses 32 1989 536 539
45. J. Faergemann H. Zehender L. Millerioux Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days Clin Exp Dermatol 19 1994 121 126
46. J. Faergemann Activity of triazole derivatives against Pityrosporum orbiculare in vitro and in vivo Ann New York Acad Sci 544 1988 348 353
47. E.M. Farber D.A. South Urea ointment in the nonsurgical avulsion of nail dystrophies Cutis 22 1978 689 692
48. M. Feuilhade R. Baran S. Goettmann Interest of the combination of 5% amorolfine nail lacquer plus terbinafine tablet in the treatment of foot dermatophyte onychomycosis with involved matrix J Eur Acad Dermatol Venereol 5 1995 S93
49. A.Y. Finlay L. Lever R. Thomas Nail matrix kinetics of oral terbinafine in onychomycosis and normal nails J Dermatol Treat 1 1990 51 53
50. Fluconazole product monograph Pfizer Canada, Inc., September 1995.
51. Fräki J, Heikkilä H, Kero M, et al: A noncomparative study of the efficacy and safety of fluconazole in the treatment of onychomycosis. J Am Acad Dermatol, in press, 1996.
52. T.J. Franz Percutaneous absorption: On the relevance of in-vitro data J Invest Dermatol 64 1975 190 195
53. J.N. Galgioni Antifungal susceptibility tests Antimicrob Agents Chemother 31 1987 1867 1870
54. K.L. Goa L.B. Barradell Fluconazole: An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients Drugs 50 1995 658 690
55. S. Goldsmith Vitamin E and onychomycosis J Am Acad Dermatol 8 1983 910 911
56. M.J.D. Goodfield Short-duration therapy with terbinafine for dermatophyte onychomycosis: A multicentre trial Br J Dermatol 126 1992 33 35
57. S.M. Grant S.P. Clissold Itraconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses Drugs 37 1989 310 344
58. J.R. Graybill Future directions of antifungal chemotherapy Clin Infect Dis 14 1992 S170 S181
59. A.K. Gupta Amorolfine: An overview Drugs of Today 31 1995 145 153
60. A.K. Gupta D.N. Sauder N.H. Shear Antifungal agents: An overview. Part I J Am Acad Dermatol 30 1994 677 698
61. A.K. Gupta D.N. Sauder N.H. Shear Antifungal agents: An overview. Part II J Am Acad Dermatol 30 1994 911 933
62. A.K. Gupta N.H. Shear Terbinafine in the treatment of superficial dermatomycoses Can J Derm 6 1994 561 565
63. Gupta AK, Shear NH: Onychomycosis—going for cure. Can Fam Physician, in press, 1996.
64. A.K. Gupta N.H. Shear D.N. Sauder New antifungal agents Curr Opin Dermatol 2 1993 200 206
65. A survey and treatment of onychomycosis in children. J Am Acad Dermatol, in press
66. E. Haneke J. Delescluse E.P.B. Plinck The use of itraconazole in onychomycosis Eur J Dermatol 6 1996 7 10
67. E. Haneke I. Tausch M. Bräutigam Shortduration treatment of fingernail dermatophytosis: A randomized, double-blind study with terbinafine and griseofulvin J Am Acad Dermatol 32 1995 72 77
68. M. Haria H.M. Bryson Amorolfine: A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections Drugs 49 1995 103 120
69. R.J. Hay Y.M. Clayton M.K. Moore A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis Clin Exp Dermatol 12 1986 175 177
70. R.J. Hay Onychomycosis: Agents of choice Dermatol Clin 11 1993 161 169
71. R.J. Hay Pharmacokinetic evaluation of fluconazole in skin and nails Int J Dermatol 31 1992 6 7
72. R.J. Hay Y.M. Clayton M.K. Moore An evaluation of itraconazole in the management of onychomycosis Br J Dermatol 119 1988 359 366
73. R.J. Hay R.M. Mackie Y.M. Clayton Tioconazole nail solution—an open study of its efficacy in onychomycosis Clin Exp Dermatol 10 1985 111 115
74. R.J. Hay Treatment of dermatomycoses and onychomycoses—state of the art Clin Exp Dermatol 17 Suppl 1 1992 2 5
75. R.J. Hay D.T. Roberts V.R. Doherty The topical treatment of onychomycosis using a new combined urea/imidazole preparation Clin Exp Dermatol 13 1988 164 167
76. J. Heeres L.J.J. Backx J. Van Custem Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones J Med Chem 27 1984 894 900
77. D. Hettinger M. Valinsky Treatment of onychomycosis with nail avulsion and topical ketoconazole J Am Podiatr Med Assoc 81 1991 28 32
78. L.G. Hochman R.K. Scher M.S. Meyerson The safety and efficacy of oral fluconazole in the treatment of onychomycosis J Geriatr Dermatol 1 1993 169 172
79. H. Hofmann M. Bräutigam G. Weidinger Treatment of toenail onychomycosis: A randomized, double-blind study with terbinafine and griseofulvin Arch Dermatol 131 1995 919 922
80. M. Ishii T. Hamada Y. Asai Treatment of onychomycosis by ODT therapy with 20% urea ointment and 2% tolnaftate ointment Dermatologica 167 1983 273 279
81. S. Jevons G.E. Gymer K.W. Brammer Antifungal activity of tioconazole (UK-20349), a new imidazole derivative Antimicrob Agents Chemother 15 1979 597 602
82. M. Johnson J.S. Comaish S. Shuster Nail is produced by the normal nail bed: A controversy resolved Br J Dermatol 125 1991 27 29
83. M. Johnson S. Shuster Determinants of nail thickness and length Br J Dermatol 130 1994 195 198
84. S. Kagawa A clinical evaluation of itraconazole, a new oral antifungal agent, in the treatment of tinea unguium, candida onychomycosis and candida onychia/paronychia The Clinical Report 25 1991 433 448
85. N.C. Karyotakis E.J. Anaissie R. Hachem Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice J Infect Dis 168 1993 1311 1313
86. J.A. Kim K.J. Ahn J.M. Kjm Efficacy and tolerability of itraconazole in patients with fingernail onychomycosis: A 6-week pilot study Curr Ther Res 56 1995 1066 1075
87. F. Klaschka Treatment of onychomycosis with naftifine gel Mycosen 30 Suppl 1 1987 119 123
88. G.S. Kobayashi E.D. Spitzer Testing of organisms for susceptibility to triazoles: Is it justified Eur J Clin Microbiol Infect Dis 8 1989 387 389
89. H.C. Korting M. Schäfer-Korting H. Zienicke Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole Antimicrob Agents Chemother 37 1993 2064 2068
90. K. Kuokkanen S. Alava Fluconazole in the treatment of onychomycosis caused by dermatophytes J Dermatol Treat 3 1992 115 117
91. J. Lauharanta Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly Clin Exp Dermatol 17 Suppl 1 1992 41 43
92. J. Lauharanta M. Zaug A. Polak Combination of amorolfine with griseofulvin: In vitro activity and clinical results in onychomycosis JAMA Southeast Asia Supplement 9 1993 23 27
93. J.L. Lesher New antifungal agents Dermatol Clin 10 1992 799 805
94. L. Matthieu P. Doncker De G. Cauwenbergh Itraconazole penetrates the nail via the nail matrix and the nail bed—An investigation in onychomycosis Clin Exp Dermatol 16 1991 374 376
95. M.S. Meyerson R.K. Scher L.G. Hochman Open-label study of the safety and efficacy of naftifine hydrochloride 1 percent gel in patients with distal subungual onychomycosis of the fingers Cutis 51 1993 205 207
96. M.S. Meyerson R.K. Scher L.G. Hochman Open-label study of the safety and efficacy of fungoid tincture in patients with distal subungual onychomycosis of the toes Cutis 49 1992 359 362
97. J.B. Montana R.K. Scher A double-blind, vehicle-controlled study of the safety and efficacy of fungoid tincture in patients with distal subungual onychomycosis of the toes Cutis 53 1994 313 316
98. F. Montero-Gei M. Robles-Soto H. Schlager Flucorazole in the treatment of severe onychomycosis Int J Dermatol 35 1996 587 588
99. C.S. Munro J.L. Rees S. Shuster The unexpectedly rapid response of fungal nail infection to short duration therapy Acta Derm Venereol 72 1992 131 133
100. C.S. Munro S. Shuster The route of rapid access of drugs to the distal nail plate Acta Derm Venereol 72 1992 387 388
101. G.T. Nahass M. Sisto Onychomycosis: successful treatment with once-weekly fluconazole Dermatology 186 1993 59 61
102. S. Nolting Non-traumatic removal of the nail and simultaneous treatment of onychomycosis Dermatologica 169 1984 117 120
103. S. Nolting M. Bräutigam G. Weidinger Terbinafine in onychomycosis with involvement by non-dermatophytic fungi Br J Dermatol 130 1994 16 21
104. F.C. Odds Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents Antimicrob Agents Chemother 36 1992 1727 1737
105. G. Petranyi J.G. Meingassner H. Mieth Antifungal activity of the allylamine derivative terbinafine in vitro Antimicrob Agents Chemother 31 1987 1365 1368
106. G. Petranyi J.G. Meingassner H. Mieth Activity of terbinafine in experimental fungal infections of laboratory animals Antimicrob Agents Chemother 31 1987 1558 1561
107. M.A. Pfaller C. Grant V. Morthland Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans J Clin Microbiol 32 1994 506 509
108. T. Piepponen Efficacy and safety of itraconazole in the long-term treatment of onychomycosis J Antimicrob Chemother 29 1992 195 205
109. G.E. Piérard J.E. Arrese P. De Doncker Antifungal activity of itraconazole and terbinafine in human stratum corneum: A comparative study J Am Acad Dermatol 32 1995 429 435
110. A.M. Polak Preclinical data and mode of action of amorolfine Clin Exp Dermatol 17 Suppl 1 1992 8 12
111. A. Polak Kinetics of amorolfine in human nails Mycoses 36 1993 101 103
112. A. Polak D.M. Dixon Antifungal activity of amorolfine (Ro14-4767/002) in vitro and in vivo R.A. Fromtling Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents 1987 J.R. Prous Science Publishers Barcelona 555 573
113. V.S.A. Qadripur G. Horn T. Höhler Zur lokalwirksamkeit von ciclopiroxolamin bei nagelmykosen Drug Res 31 1981 1369 1372
114. D. Reinel C. Clarke Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly Clin Exp Dermatol 17 Suppl 1 1992 44 49
115. J.H. Rex M.G. Rinaldi M.A. Pfaller Resistance of candida species to fluconazole Antimicrob Agents Chemother 39 1995 1 8
116. K. Richardson K.W. Brammer M.S. Marriott Activity of UK-49, 858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes Antimicrob Agents Chemother 27 1985 832 835
117. D.T. Robert M.D. Richardson P.K. Dwyer Terbinafine in chronic paronychia and Candida onychomycosis J Dermatol Treat 3 1992 39 42
118. O. Rollman Treatment of onychomycosis by partial nail avulsion and topical miconazole Dermatologica 165 1982 54 61
119. O. Rollman S. Johansson Hendersonula toruloidea infection: Successful response of onychomycosis to nail avulsion and topical ciclopiroxolamine Acta Derm Venereol 67 1987 506 510
120. G. Roncari C. Ponelle R. Zumbrunnen Percutaneous absorption of amorolfine following a single topical application of an amorolfine cream formulation Clin Exp Dermatol 17 1992 33 36
121. D. Roseeuw P. Doncker De New approaches to the treatment of onychomycosis J Am Acad Dermatol 29 1993 S45 S50
122. E. Rothermel D.B. Apfelberg Carbon dioxide laser use for certain diseases of the toenails Clin Podiatr Med Surg 4 1987 809 821
123. N.S. Ryder Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent Antimicrob Agents Chemother 27 1985 297 300
124. N.S. Ryder Terbinafine: Mode of action and properties of the squalene epoxidase inhibition Br J Dermatol 126 Suppl 39 1992 2 7
125. N.S. Ryder M.-C. Dupont Inhibition of squalene epoxidase by allylamine antimycotic compounds Biochem J 230 1985 765 770
126. R.K. Scher J.M. Barnett Successful treatment of Aspergillus flavus onychomycosis with oral itraconazole J Am Acad Dermatol 23 1990 749 750
127. H.J. Schmitt J. Andrade F. Edwards Inactivity of terbinafine in a rat model of pulmonary aspergillosis Eur J Clin Microbiol Infect Dis 9 1990 832 835
128. N.H. Shear A.K. Gupta Terbinafine for the treatment of pedal onychomycosis: A foot closer to the promised land of cured nails Arch Dermatol 131 1995 937 942
129. S. Shuster C. Munro Single dose treatment of fungal nail disease Lancet 339 1992 1066
130. S.W. Smith D.P. Sealy E. Schneider An evaluation of the safety and efficacy of fluconazole in the treatment of onychomycosis South Med J 88 1995 1217 1220
131. D.A. South E.M. Farber Urea ointment in the nonsurgical avulsion of nail dystrophies—A reappraisal Cutis 25 1980 609 612
132. A. Stutz Synthesis and structure-activity correlations within allylamine antimycotics Ann NY Acad Sci 544 1988 46 62
133. D.W.R. Suringa Treatment of superficial onychomycosis with topically applied glutaraldehyde Arch Dermatol 102 1970 163 167
134. J.M. Torres-Rodriguez N. Madrenys M.C. Nicolás Non-traumatic topical treatment of onychomycosis with urea associated with bifonazole Mycoses 34 1991 499 504
135. H. Ulbricht K. Wörz Therapy of onychomycosis due to moulds with ciclopirox nail lacquer Mycoses 37 1994 97 100
136. Drug information for the health care professional 1996 Rand McNally Taunton, MA 300
137. J. Cutsem Van Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals Mycoses 32 Suppl 1 1989 14 34
138. J. Van Cutsem F. Gerven Van P.A.J. Janssen Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: Animal models Rev Infect Dis 9 1987 S15 S32
139. H. Bossche Vanden P. Marichal J. Gorrens Biochemical approaches to selective antifungal activity. Focus on azole antifungals Mycoses 32 1989 35 52
140. J.G. Van Der Schroeff P.K.S. Cirkel M.B. Crijns A randomized treatment duration-finding study of terbinafine in onychomycosis Br J Dermatol 126 1992 36 39
141. V. Villars T.C. Jones Clinical efficacy and tolerability of terbinafine (Lamisil)—A new topical and systemic fungicidal drug for treatment of dermatomycoses Clin Exp Dermatol 14 1989 124 127
142. V.V. Villars T.C. Jones Special features of the clinical use of oral terbinafine in the treatment of fungal diseases Br J Dermatol 126 1992 61 69
143. T.J. Walsh S. Aoki F. Mechinaud Effects of preventive early and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis J Infect Dis 161 1990 755 760
144. I. Walsoe M. Stangerup E. Svejgaard Itraconazole in onychomycosis: Open and double-blind studies Acta Derm Venereol 70 1990 137 140
145. V.H. Weuta Clotrimazol-creme und -lösung-klinische prüfung im offenen versuch Drug Res 22 1972 1295 1299
146. M.I. White Y.M. Clayton The treatment of fungus and yeast infections of nails by the method of chemical removal Clin Exp Dermatol 7 1982 273 276
147. A. Wildfeuer J. Faergemann H. Laufen Bioavailability of fluconazole in the skin after oral medication Mycoses 37 1994 127 130
148. M. Willemsen P. Doncker De J. Willems Post treatment itraconazole levels in the nail J Am Acad Dermatol 26 1992 731 735
149. J.R. Wingard W.G. Merz M.G. Rinaldi Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients Antimicrob Agents Chemother 37 1993 1847 1849
150. C.K. Wong Y.L. Cho Very short duration therapy with oral terbinafine for fingernail onychomycosis Br J Dermatol 133 1995 329 347
151. Y.C. Wu M.T. Chuan Y.C. Lü Efficacy of ciclopiroxolamine 1% cream in onychomycosis and tinea pedis Mycoses 34 1991 93 95
152. N. Zaias Management of onychomycosis with oral terbinafine J Am Acad Dermatol 23 1990 810 812
153. N. Zaias A. Tosti G. Rebell Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum J Am Acad Dermatol 34 1996 302 304
154. M. Zaug M. Bergstraesser Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview) Clin Exp Dermatol 17 1992 61 70
155. H. Zehender J. Denouë J. Faergemann Elimination kinetics of terbinafine from human plasma and tissues following multiple-dose administration, and comparison with 3 main metabolites Drug Invest 8 1994 203 210
156. J.M. Zuckerman A.R. Tunkel Itraconazole: A new triazole antifungal agent Infect Control 15 1994 397 410